platinum has been researched along with Bone Cancer in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, GH; Deng, YW; Li, SH; Li, YJ; Li, YW; Lu, D | 1 |
| Cai, Z; Hua, Y; Jiang, L; Jiang, W; Jiang, Y; Lin, J; Liu, F; Lv, G; Lv, Y; Ma, X; Mu, H; Shen, J; Sun, M; Sun, W; Tang, Y; Tian, K; Wang, C; Wang, G; Wang, H; Wang, J; Wang, S; Wang, Z; Xu, J; Xue, L; Yang, L; Yin, F; Yu, S; Zhang, T; Zhao, K; Zhou, Z; Zuo, D | 1 |
| Bassi, G; Campodoni, E; Dempsey, E; Montagner, D; Montesi, M; Moynihan, E; Panseri, S; Rossi, A; Velasco-Torrijos, T | 1 |
| Lim, YY; Miskon, A; Zaidi, AMA | 1 |
| Huang, X; Wang, J; Yue, H; Zhang, M | 1 |
| Agarwal, N; Bamias, A; Baniel, J; Bellmunt, J; Berthold, DR; Bowles, DW; Crabb, S; Galsky, MD; Harshman, LC; Ladoire, S; Necchi, A; Niegisch, G; Pal, SK; Plimack, ER; Pond, GR; Powles, T; Rosenberg, JE; Srinivas, S; Yu, EY | 1 |
| Cai, X; Cheng, Y; Deng, H; Fan, T; Song, D; Xiao, J; Yan, Y; Zhang, Q; Zhang, S; Zhou, Y; Zhou, Z | 1 |
| Cai, X; Cheng, Y; Ge, H; Huang, Q; Wang, C; Wang, X; Wang, Y; Xiao, J; Yan, W; Zhang, J; Zhang, Q | 1 |
| Hu, WJ; Liu, BR; Liu, XZ; Qian, XP; Shi, MQ; Wei, J; Zou, ZY | 1 |
| Gandin, V; Margiotta, N; Marzano, C; Natile, G; Ostuni, R; Piccinonna, S | 1 |
| Katsuda, H; Katsura, H; Miyamoto, K; Nagata, N; Sai, Y; Waki, Y; Yamashita, M; Yu, J | 1 |
| Aso, M; Ekimoto, H; Nakatake, H; Ogawa, A; Suemune, H; Yamaguchi, A | 1 |
| Kang, WK; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS; Yi, JH; Yim, DS | 1 |
| Iafisco, M; Margiotta, N | 1 |
| Cormio, G; Cuccovillo, A; Fattizzi, N; Loizzi, V; Selvaggi, L | 1 |
| Boos, J; Deuster, D; Dinnesen, AG; Jaehde, U; Krefeld, B; Lanvers-Kaminsky, C; Pieck, AC; Seifert, E; Würthwein, G | 1 |
| Avidor, I; Cohen, IJ; Goshen, Y; Kaplinsky, C; Katz, K; Mor, C; Yaniv, Y; Yosipovitch, Z; Zaizov, R | 1 |
| Butenko, AK; Glukhovskaia, IIu; Konovalenko, VF; Tolstopiatov, BA | 1 |
| Caserini, C; Colangelo, D; Farrell, N; Gatti, L; Leone, R; Perego, P; Spinelli, S; Supino, R; Zunino, F | 1 |
| de Vries, EG; Guchelaar, HJ; Hoekstra, HJ; Oosterhuis, JW; Schraffordt Koops, H; Uges, DR | 1 |
| Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M | 1 |
| Bielack, SS; Delling, G; Erttmann, R; Landbeck, G; Looft, G; Purfürst, C; Winkler, K | 1 |
3 review(s) available for platinum and Bone Cancer
| Article | Year |
|---|---|
Combining Copper and Zinc into a Biosensor for Anti-Chemoresistance and Achieving Osteosarcoma Therapeutic Efficacy.
Topics: Antineoplastic Agents; Biosensing Techniques; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Copper; Drug Resistance, Neoplasm; Humans; Osteosarcoma; Platinum; Zinc | 2023 |
Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: a mini-review.
Topics: Antineoplastic Agents; Bone Neoplasms; Bone Substitutes; Coordination Complexes; Diphosphonates; Drug Delivery Systems; Durapatite; Humans; Nanoparticles; Platinum; Prodrugs; Silica Gel | 2012 |
Two cases of endometrial cancer diagnosis associated with bone metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Cervical Vertebrae; Cyclophosphamide; Diphosphonates; Doxorubicin; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Imidazoles; Middle Aged; Platinum; Spinal Neoplasms; Tibia; Zoledronic Acid | 2006 |
2 trial(s) available for platinum and Bone Cancer
| Article | Year |
|---|---|
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Platinum; Pyrroles; Salvage Therapy; Stomach Neoplasms; Sunitinib; Survival Rate; Taxoids; Tissue Distribution; Treatment Outcome; Young Adult | 2012 |
Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSS.
Topics: Bone Neoplasms; Cisplatin; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Multicenter Studies as Topic; Osteosarcoma; Platinum | 1989 |
17 other study(ies) available for platinum and Bone Cancer
| Article | Year |
|---|---|
Advanced thymic lymphoepithelioma-like carcinoma with bone marrow metastases treated by immunotherapy combined with antiangiogenesis therapy: a case report.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Squamous Cell; Humans; Immunotherapy; Platinum | 2022 |
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.
Topics: Adolescent; Bone Neoplasms; Child; Genomics; Humans; Osteosarcoma; Platinum; Transcriptome; Young Adult | 2022 |
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Carbohydrates; Cell Line, Tumor; Cisplatin; Coordination Complexes; Humans; Osteosarcoma; Platinum; Prodrugs | 2023 |
Multiproperty Polyethylenimine-Caged Platinum Nanoclusters Promote Apoptosis of Osteosarcoma Cells via Regulating the BAX-Bcl-2/Caspase-3/PARP Axis.
Topics: Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Caspase 3; Child; Humans; Osteosarcoma; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Polyethyleneimine | 2023 |
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Transitional Cell; Disease-Free Survival; Female; Humans; Male; Middle Aged; Platinum; Prognosis; Retrospective Studies; Treatment Outcome; Urologic Neoplasms | 2018 |
One stone with two birds: Phytic acid-capped platinum nanoparticles for targeted combination therapy of bone tumors.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Drug Delivery Systems; Humans; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Phytic Acid; Platinum | 2019 |
Trifolium-like Platinum Nanoparticle-Mediated Photothermal Therapy Inhibits Tumor Growth and Osteolysis in a Bone Metastasis Model.
Topics: Animals; Biocompatible Materials; Body Weight; Bone Neoplasms; Cell Line; Cell Line, Tumor; HeLa Cells; Humans; Imaging, Three-Dimensional; Infrared Rays; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Electron, Transmission; Neoplasm Metastasis; Neoplasms; NIH 3T3 Cells; Osteolysis; Photochemistry; Phototherapy; Platinum; Platinum Compounds; Povidone; Tomography, X-Ray Computed; Trifolium; X-Ray Microtomography | 2015 |
[Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; DNA-Binding Proteins; Endonucleases; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paraffin Embedding; Platinum; Proportional Hazards Models; RNA, Messenger; Survival Rate | 2009 |
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Coordination Complexes; Diphosphonates; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Platinum; Prodrugs | 2009 |
Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line; Cell Line, Tumor; Cimetidine; Cisplatin; Infusions, Intravenous; Kidney; Male; Organic Cation Transport Proteins; Osteosarcoma; Platinum; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Agents | 2010 |
Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor.
Topics: Adsorption; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Diphosphonates; Durapatite; Humans; Neoplasm Metastasis; Osteoclasts; Platinum | 2011 |
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Hearing Loss, Sensorineural; Humans; Infant; Infusions, Intravenous; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Osteosarcoma; Platinum; Prospective Studies | 2006 |
Improved results in osteogenic sarcoma 1973-79 vs. 1980-86: analysis of results from a single center.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Life Expectancy; Male; Methotrexate; Osteosarcoma; Platinum; Prognosis; Survival Analysis; Treatment Outcome | 1993 |
[Current aspects of the treatment of osteogenic sarcoma].
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate; Osteosarcoma; Platinum; Time Factors | 1995 |
The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Antineoplastic Agents; Base Pair Mismatch; Bone Neoplasms; Carcinoma; Carrier Proteins; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA Polymerase beta; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Organoplatinum Compounds; Osteosarcoma; Platinum; Proteins; Proto-Oncogene Proteins; Tumor Cells, Cultured | 1999 |
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
Topics: Adult; Aged; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Extremities; Fever; Histiocytoma, Benign Fibrous; Humans; Melanoma; Middle Aged; Osteosarcoma; Platinum; Tissue Distribution | 1992 |
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction | 1990 |